In summary, our study provides solid evidence supporting the hypothesis that LNMAT1 overexpression is clinically and functionally relevant to the lymphatic metastasis of human bladder cancer via CCL2-mediated modulation of the tumor microenvironment. This evidence concerns the gene CCL2 and urinary bladder cancer.